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Basics of mechanical ventilation for non-aneasthetists. 
Part 2: Clinical aspects
Abstract
Invasive and non-invasive mechanical ventilation (MV) continues to be the most significant life support method. It is, however, 
coupled with many risks. Historically, concepts of MV did focus on improving the arterial blood gas results rather than preventing 
harmful side-effects of positive pressure ventilation. Since then, multiple studies exploring this matter emerged and led to the 
protective MV concept. The golden mean between assuring the best oxygenation and limiting the ventilator-induced lung injury 
(VILI) is still a matter of debate. These considerations are especially impactful while treating patients with adult respiratory dis-
tress syndrome (ARDS), where the limitation of MV’s negative effect is specifically important. This paper explores the protective 
ventilation concept and clinical implications of the latter. 
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Introduction
Mechanical ventilation must be carried out 
exceptionally cautiously and take into account: 
indications and contraindications for its imple-
mentation, the clinical condition of the patient, 
the technical capabilities of the ward, and the 
skills of the staff. It is important to adjust therapy 
to the patient, not vice versa — the way of ven-
tilation changes over time, taking into account, 
in particular, the current results of arterial blood 
tests which reflect the progression or regression 
of the disease. It is advisable to perform imaging 
and diagnostic-therapeutic bronchofibersocopy 
tests, especially in patients with known atel-
ectasis. Even the safest mechanical ventilation 
poses a risk, the consequences of which affect 
the patient. Lung damage is an almost inevitable 
complication of respiratotherapy.
Ventilator-induced lung injury 
Ventilator-induced lung injury (VILI) is a form 
of ventilator-associated lung injury (VALI), which 
is a broader concept and refers to all forms of lung 
damage in ventilated patients. Ventilator-induced 
lung injury means that the connection between 
ventilation and damage has been proven. The 
use of too high pressures in the respiratory tract 
leads to damage in the lung tissue, so-called 
barotrauma, which from today’s perspective, may 
seem like a historical issue. In the past, when 
the concept of safe ventilation was not present, 
the formation of subcutaneous emphysema, 
pneumothorax, pneumomediastinum, or air em-
bolism was not uncommon [1]. The presence of 
such complications indicates the macroscopic 
disintegration of the lungs. It must be noted, 
however, that the direct cause of such damage is 
not the pressure in the respiratory tract, but the 
pressure applied to the lungs themselves, where 
the most important role is played by the so-called 
transpulmonary pressure (the difference between 
the pressure in the alveoli and the pressure in 
the pleural cavity). Dreyfuss et al. in the 1980s 
conducted an experiment in which rats were 
ventilated with high pressure, with one group 
of animals wearing stripes to prevent lung and 
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thoracic expansion during ventilation — the other 
did not. In both groups, very high pressures were 
achieved in the respiratory tract, but there was no 
lung damage in the group of rats with clenched 
belts, while individuals without belts experienced 
damage [2]. This experiment, thanks to the arti-
ficial reduction in the compliance of the chest, 
achieved low values of transpulmonary pressure 
(due to increased pressure in the pleural cavity), 
which prevented barotrauma (and VILI). The 
reason why rats without a stiffened chest showed 
more considerable lung damage was therefore 
caused not by the pressure itself, but the higher 
respiratory volume obtained — hence the new 
term emerged — volutrauma. Considerations on 
VILI can be further extended with an analysis of 
the formula for transpulmonary pressure:
PL [cmH2O] = K × VT/FRC.
Where “PL” means transpulmonary pressure, 
“K” — specific pulmonary elastance, “VT” — re-
spiratory volume, and “FRC” is the functional 
residual capacity of the lungs. The equation 
above directly combines the respiratory volume 
with transpulmonary pressure, meaning that the 
concept of pressure and volume damage is closely 
related. An equally important component of the 
design is also FRC which is reduced, e.g., acute 
respiratory distress syndrome [3], increasing 
PL. The use of low respiratory volumes reduc-
es transpulmonary pressure, and therefore the 
risk of VILI [4]. Pumping the air into the lungs 
by producing positive pressure also carries the 
risk of cyclic opening and closing of the alve-
oli. Slutsky et al. in 1997 discovered that such 
repeated recruitment and derecruitment of the 
alveoli also harm the tissue by promoting inflam-
mation — this experiment created the concept of 
atelectrauma [5]. Taking Mead’s physical consid-
erations into account and the fact that in partially 
collapsed lungs (e.g. ARDS), the applied pressure 
can induce extremely different transpulmonary 
pressure values – in one place the pressure PL may 
be 30 cmH2O and in another even 140 cmH2O (!), 
which becomes a pressure critically damaging 
to the lung tissue [6]. As mentioned above, lung 
damage can be done not only mechanically, but 
also by induction and promotion of inflamma-
tion in the biochemical sense — biotrauma [7]. 
Mechanical ventilation forces deforming the al-
veoli also affect immune cells. There is increased 
secretion of pro-inflammatory cytokines, fibrosis 
processes and radical stress. It has been docu-
mented that after two-hour ventilation with high 
volumes of rat lungs, TNF-a, IL-1-b, IL-6, IL-10, 
MIP-2, and IFN-g concentrations increased signifi-
cantly [8]. Such a cytokine storm can enter the 
systemic circulation and worsen the course of the 
underlying lung disease, leading to catastrophic 
complications [9].
In recent years, attempts have been made 
to unify the problem of lung damage by creating 
a formula for the so-called mechanical power 
(MP), the value of which could reflect the degree 
of harmfulness of the parameters of the ventilator 
on the lung tissue. Such formula was proposed 
by L. Gattinoni et al. [10]:





60 × I:E  DV × PEEP.
Where RR — breaths/min, DV — respiratory 
volume, E — respiratory elastance, R — respi-
ratory resistance, PEEP — positive end-expira-
tory pressure, I:E — inhalation time-to-exhaust 
ratio. The clinician should strive to minimise 
the power of mechanical ventilation even at the 
expense of lower saturation [permissive hypox-
emia — SaO2 between 85–95% and carbon dioxide 
retention (permissive hypercapnia — pCO2 65–
85 mmHg)] [11]. It has been proven that a power 
greater than 12 J/min carries a higher risk of 
complications [12]. It must be remembered that 
low MP may not be acceptable in patients with 
severe ARDS, whose ventilation parameters must 
be chosen in a way to guarantee the minimum, 
necessary for survival oxygenation. It is therefore 
suggested that in mild ARDS, the power should be 
lower than 17 J/min, moderate ARDS < 22 J/min, 
and in severe < 27 J/min [13]. 
Parameters of safe mechanical ventilation
The concept of safe mechanical ventilation 
(LPV) applies to all patient groups, both those 
with healthy and diseased lungs, that is, both 
in the operating block and in the ICU. In both 
groups, complications are observed after the use 
of such parameters: postoperative respiratory 
complications in anaesthesiology and a reduction 
in ventilation time and faster ARDS resolution 
in intensive care. A protective, cost-effective 
ventilation strategy in the operating room is not 
associated with any additional intraoperative risk 
in the operated persons [15].
Breathing volume (VT, tidal volume) is de-
signed to guarantee an adequate amount of air 
entering the lungs, and thus delivering oxygen 
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and removing carbon dioxide. The higher the 
respiratory volume, the easier these assumptions 
are achieved. Unfortunately, excessive respira-
tory volume leads to lung damage. A number 
of studies were conducted comparing lower VT 
values of 6–8 mL/kg of ideal body weight (IBW) 
with higher values of 9–15 mL/kg IBW. In those 
patients who were treated with small volumes, 
a decrease in mortality (by 30–40%), fewer com-
plications and fewer cases of VILI were observed 
[15]. According to current guidelines, it is there-
fore recommended to reduce VT to ≤ 6–7 mL/kg 
IBW [16], as it leads to relatively small inflation 
of lung tissue. Breathing volume is the most 
essential element of the formula for the power 
of mechanical ventilation. Hence, any efforts 
to reduce MP should begin with an attempt to 
optimise this parameter [10].
Plateau pressure is the pressure achieved in 
the respiratory tract after stopping the inhalation 
flow and before exhalation — the so-called inha-
lation pause. It depends on the compliance of the 
respiratory system and in some way, determines 
the degree of lung distension. If the patient is 
ventilated with a safe volume of 6 mL/kg, the 
values of this pressure should also be monitored 
so that they do not exceed 30 cmH2O [11]. The 
high value of this parameter is an independent 
risk factor for death in ventilated patients [17]. 
Driving pressure (DP) is the difference be-
tween plateau pressure and end-expiratory pres-
sure obtained in the airways. It reflects the 
dynamic changes to which the lung is subjected. 
Currently, this parameter is considered the most 
reliable VILI predictor, both in patients with 
ARDS and in those with healthy lungs undergoing 
general anaesthesia [18]. It is recommended to 
reduce the DP to a value below 14 cmH2O [18]. 
However, it must be remembered that the driv-
ing pressure is not an independent variable. To 
achieve safe values for this parameter, one needs 
to modify the plateau pressure (depending on the 
respiratory volume and pulmonary elastance) 
and the positive end-expiratory pressure (PEEP) 
value. However, it must not be the case that, in 
order to reduce the DP, uncontrolled increases in 
PEEP values are allowed. It is conceivable that 
the paradoxically safe value of DP = 12 cmH2O 
can be dangerous if the set PEEP is too high or 
too low [19].
When a healthy person ends expiration, the 
respiratory system naturally (thanks to the re-
sistance of the upper respiratory tract) produces 
some positive pressure so that the alveoli do not 
collapse [20]. That is why it is so important to 
produce PEEP during mechanical ventilation. 
Optimal PEEP can effectively counter lung depri-
vation, cyclic recruitment and derecruitment of 
the alveoli (atelectrauma, VILI) and improve gas 
exchange and the ventilation-perfusion ratio [21]. 
Insufficient PEEP leads to a deterioration in re-
spiratory work and VILI development. An equally 
important problem is also the higher value of this 
parameter: large PEEP, acting on the alveoli, can 
lead to excessive lung stretching (so-called static 
strain increase), which elevates inflammation of 
the tissue and therefore promotes VILI [22]. Ex-
cessive PEEP also presses down large pulmonary 
vessels, impairing venous return, i.e. reducing the 
cardiac output [23], and also slightly damages the 
outflow of lymph. It has been documented that 
PEEP ≥ 15 cmH2O is associated with excessive 
lung stretching and haemodynamic impairment 
[24]. From the point of view of mechanical power 
(MP), higher PEEP also means the more required 
energy needed to be delivered to the patient’s 
lungs, and therefore can contribute to the for-
mation of VILI [10]. The randomised PROVHILO 
study examined patients undergoing abdominal 
surgery, ventilated or PEEP = 2 cmH2O or PEEP = 
12 cmH2O. No adverse effects of higher PEEP val-
ues were observed, while the lower pressure PEEP 
group had a detrimental effect of cyclic opening 
and closing of follicles [25]. Various strategies for 
ventilation of patients without ARDS ventilated in 
the intensive care unit were also assessed, where 
the strategy — low VT (< 8 mL/H2O) + low PEEP 
(< 10 cmH2O) was associated with a shorter stay 
at the ICU, and the strategy — low VT + high 
PEEP (> 10 cmH2O) – was linked with improved 
Table 1. The most common causes and classification 
of  acute respiratory distress syndrome (ARDS) 
[14, self-modification]
The most common causes of ARDS 
• Sepsis 
• Severe pneumonia 
• Injuries 
• Aspiration of harmful substances (e.g. stomach content) 
• Other — massive blood transfusions, acute pancreatitis, etc. 
Mild ARDS Moderate ARDS Severe ARDS 
Horowitz index (PaO2/FiO2), at PEEP ≥ 5 cmH2O 
300–201 101–200 < 100 
FiO2 — oxygen concentration in the respiratory mixture (in decimal numbers); 
pO2 — partial pressure of oxygen in the arterial blood (mm Hg)
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oxygenation of the patient’s blood [26]. It seems 
that subjects with healthy lungs can start venti-
lation with PEEP = 5 cmH2O, as this mimics the 
natural PEEP and protects against the harmful 
effects of its absence [27]. The problem arises in 
treatment of ARDS (Table 1) where there is a mas-
sive lung deterioration and PEEP values must be 
high enough to expand the collapsed lungs and, 
thus ensure normal oxygenation. The ART study 
looked at patients with ARDS ventilated with an 
open lung ventilation strategy using the so-called 
“open lung ventilation” Recruitment manoeuvres 
(one-time lifting of PEEP pressures to a value of 
45 cmH2O) and PEEP titration, following the prin-
ciple of obtaining maximum static compliance 
(Cstat = VT/Pplat). The control group in this study 
was a group of patients treated with ARDSnet (Ta-
ble 2) using low PEEP and low VT values. Not only 
did the study experience three sudden cardiac 
arrests due to recruitment manoeuvres, a higher 
mortality rate in the study group (in patients with 
moderate ARDS) was observed [28]. This calls 
into question the concept of ARDS treatment of 
“lung opening” [29] and begins a discussion on 
a new look, involving minimal deformation of 
the lungs with low or moderate PEEP values (up 
to 15 cmH2O) [23].
The respiratory rate (RR) should ensure the 
correct elimination of carbon dioxide from the 
body, so this variable should be adjusted to the 
results of carbon dioxide pressure (pCO2) in blood 
gas. PCO2 pressure is considered to be normal 
between 35–45 mm Hg (normocapnia) [31]. The 
breathing rate of 8–12/min is generally sufficient 
in patients without lung damage, mainly in the 
operating room [32]. Ventilation of patients with 
ARDS following LPV principles, due to low VT 
values, often requires an increase in RR. Thus, 
in patients with ARDS, the ventilation rate can 
be up to 35/min [30]. It should be remembered 
that the RR parameter is also present in the 
formula for the power of ventilation and its rise 
contributes to the growth of the MP, therefore, 
increases the risk of VILI: the animal model study 
showed that ventilation, even with very harmful 
volumes, depending on the breath frequency, can 
significantly model the risk of death [33]. In order 
to reduce VILI in ARDS patients, limiting RR to 
~30 breaths/min may result in the so-called per-
missive hypercapnia [11], with the development 
of respiratory acidosis.
The oxygen concentration in the breath-
ing mixture during mechanical ventilation can 
range from 21% to 100% (0.21–1.0). It should be 
remembered, however, that due to the harmful 
effects of aerobic radicals and resorption atel-
ectasis, it is recommended not to increase the 
oxygen fraction (FiO2) above 0.6 [34]. There are 
studies documenting that hyperoxia increases 
mortality in intensive care units [35]. For this 
reason, a conservative oxygen therapy strategy is 
recommended to maintain oxygen pressure in the 
blood (pO2) within 70–100 mm Hg and saturation 
(SpO2) at 94-98% [36]. For ARDS patients, stricter 
values can be used: 55–80 mm Hg and 88–95%, 
respectively [30].
Non-invasive ventilation (NIV)
In recent years, the importance of non-in-
vasive ventilation has been growing, both in 
hospital wards and in home therapy [37]. There 
are reports that this method may be the first-line 
treatment in different types of acute respiratory 
failure (ARF) [38]. One ought to remember that 
the rules of invasive ventilation in the ICU cannot 
be directly transmitted to non-invasive ventila-
tion (NIV). Non-invasive ventilation differs from 
invasive ventilation primarily by the lack of the 
need to put on an artificial respiratory tract (in-
tubation tube), and instead uses special masks 
(nasal, oronasal, full face or ventilation helmets), 
closely adjacent to the patient’s face. In terms of 
a mere method, NIV is also based on ventilation 
with positive pressures, but it is necessary to 
remember that the patient himself must initiate 
a breath. Calculation of tidal volume during NIV 
differs as well. It is important to note that due 
Table 2. ARDSnet mechanical ventilation strategy [30] 
FiO2 0,3 0,4 0,4 0,5 0,5 0,6 0,7 0,7 0,7
PEEP 5 5 8 8 10 10 10 12 14
FiO2 0,8 0,9 0,9 0,9 1,0
PEEP 14 14 16 18 18–24
FiO2 — oxygen concentration in the respiratory mixture (in decimal numbers); PEEP — positive end-expiratory pressure
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Figure 1. Protocol for a sudden drop in SpO2 management. ABG — arterial blood gas; CT — computed tomography; SpO2 — peripheral capillary 
oxygen saturation; USG — ultrasonography
Figure 2. High respiratory system pressure protocol. CT — computed tomography; Horowitz index — the ratio of partial pressure arterial oxygen 
(PaO2 and fraction of inspired oxygen); USG — ultrasonography
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to possible gas leakage via imperfect mask ad-
hesion, inspiratory volume is often higher than 
the expiratory volume. The biggest advantage of 
NIV seems to be minimising the risk of ventila-
tor-associated pneumonia [39], although the risk 
of VILI cannot be eliminated entirely. NIV does 
not require sedation and can be used periodically 
Figure 3. Protocol for hyperoxemia management. FiO2 — oxygen con-
centration in the respiratory mixture; I:E ratio — inspiratory:expiratory 
ratio; pO2 — partial pressure of oxygen in the arterial blood (mm Hg); 
SpO2 — peripheral capillary oxygen saturation
Figure 4. Protocol for hypoxemia management. I:E ratio — inspira-
tory:expiratory ratio; pO2 — partial pressure of oxygen in the arterial 
blood (mm Hg); SpO2 — peripheral capillary oxygen saturation
(one-, two-hour sessions, ventilation during 
sleep). As well as invasive ventilation, NIV meets 
the basic assumptions of respiratory support as it 
reduces respiratory work (WOB), facilitates the 
procurement of O2, CO2 removal and expands 
collapsed regions of the lung.
Current indications for starting NIV for ARF 
are clearly described in the European Respiratory 
Society and American Thoracic Society clinical 
practice guidelines published in 2017 [40]. The 
major indication is the exacerbation of chronic ob-
structive pulmonary disease (COPD). Support for 
the patient with non-invasive ventilation reduces 
dyspnoea, tachypnoea, improves VT, decreases 
pCO2 and faster normalises pH [41]. Non-invasive 
ventilation in COPD reduces mortality and the 
need for intubation [42]. Another indication for 
NIV is cardiogenic pulmonary oedema, as it not 
only improves blood oxygenation but also reduces 
the afterload of the left ventricle by optimising 
transmural pressure. It reduces the need for ox-
ygen in the heart muscle, which translates into 
an improvement in prognosis [43].
Furthermore, an interesting indication for 
NIV is an ARF in patients undergoing immuno-
suppression. It has been proven that in individ-
uals during immunosuppressive treatment (e.g. 
after organ transplantations) who developed 
acute respiratory failure, the use of NIV led to 
intubation avoidance, shortest treatment time 
and reduced mortality [44]. Another indication 
for NIV is weaning from mechanical ventila-
tion, as it helps to avoid reintubation, shortens 
the length of stay in the ICU and reduces the 
incidence of pneumonia [45]. Finally, ARF as 
a postoperative complication or ARF as a result 
of lung injury are other essential indications for 
NIV [40]. In addition to the above-mentioned 
main indications, there are still many additional 
ones, namely neuromuscular diseases, chest in-
juries, kyphoscoliosis, obstructive sleep apnoea, 
obesity hypoventilation syndrome) [46–48]. NIV 
is absolutely contraindicated in patients with-
out effective respiratory drive, with impaired 
consciousness, in those with unstable haemo-
dynamics and in people at risk of aspiration of 
food content [49].
Selection of a proper interface that fits prop-
erly is of paramount importance for the success 
of NIV [50]. A significant risk of NIV failure is 
the mismatch of masks and helmets, which must 
stick tightly to the patient’s face. An oversight in 
this matter can lead to a critical escape of gases 
from the system and result in a decline of breath 
support. It should also be remembered that a mask 
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Figure 5. Protocol for hypocapnia management. IBW — ideal body 
weight; pCO2 — partial pressure of carbon dioxide in the arterial blood 
(mm Hg); Vt — tidal volume
Figure 6. Protocol for hypercapnia management. IBW — ideal body 
weight; pCO2 — partial pressure of carbon dioxide in the arterial blood 
(mm Hg); RR — respiratory rate; Vt — tidal volume
remains the patient. Be aware of the limitations 
and dangers of positive pressure, which, despite 
being at odds with the physiological way of 
breathing, is now the most common method of 
respiratory support in respiratory failure. Venti-
lation should be adapted to the patient accord-
ing to personalised therapy. Basic knowledge of 
mechanical ventilation is essential for doctors 
specialising in other fields than anaesthesiology 
and intensive therapy, especially to those before 
the planned internship at the ICU.
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that is too tight or using NIV for too long can 
lead to serious facial skin damage. In the acute 
setting, oronasal or full face masks are prefer-
able to nasal masks because dyspneic patients 
are mouth breathers, predisposing to greater air 
leakage during nasal mask ventilation [50]. In 
nonhypercapnic patients, helmet application may 
be preferred [50].
Basic protocols for the most common 
disruptions in respiratotherapy
Finally, a simple pack of protocols for most 
frequent problems occurring during invasive 
mechanical ventilation should be learned by 
all practitioners providing MV (Figure 1–6). For 
NIV, a modified algorithm should be applied 
(Figure 7).
Conclusions 
Respiratotherapy includes the integration of 
many components, the most important of which 
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